Early diagnosis of acute kidney injury in critically ill patients

Expert Review of Molecular Diagnostics

Volumn 8, Issue 4, 2008, Pages 455-464

  Keyes, Robert ^a   Bagshaw, Sean M ^a  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

Acute kidney injury; Acute renal failure; Biomarker; Cystatin C; Enzymuria; IL 18; KIM 1; Mortality; NGAL; NHE3; Renal replacement therapy

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; FETUIN A; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE ALPHA; GLUTATHIONE TRANSFERASE P1; GLYCOPROTEIN; INDUCIBLE CYSTEINE RICH PROTEIN; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; LACTATE DEHYDROGENASE; MEPRIN 1 ALPHA; MICROSOMAL AMINOPEPTIDASE; NETRIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SODIUM; SODIUM PROTON EXCHANGE PROTEIN 3; UREA;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ENZYMURIA; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY INJURY; MICROALBUMINURIA; MICROSCOPY; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTEINURIA; REVIEW; SODIUM URINE LEVEL; UREA BLOOD LEVEL; UREMIA; URINE VOLUME;

ACUTE DISEASE; BIOLOGICAL MARKERS; CHRONIC DISEASE; HUMANS; KIDNEY; KIDNEY DISEASES; TIME FACTORS;

EID: 46949095635     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.8.4.455     Document Type: Review

References (97)

1. Bagshaw SM, Laupland KB, Doig CJ et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit. Care 9, R700-R709 (2005).
2. de Mendonca A, Vincent JL, Suter PM et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 26, 915-921 (2000).
3. Liano F, Junco E, Pascual J, Madero R, Verde E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. Kidney Int. Suppl. 66, S16-S24 (1998).
4. Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294, 813-818 (2005).
5. Metnitz PG, Krenn CG, Steltzer H et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit. Care Med. 30, 2051-2058 (2002).
6. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am. J. Med. 104, 343-348 (1998).
7. Korkeila M, Ruokonen E, Takala J. Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med. 26, 1824-1831 (2000).
8. Mehta RL, Pascual MT, Soroko S et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 66, 1613-1621 (2004).
9. Morgera S, Kraft AK, Siebert G, Luft FC, Neumayer HH. Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am. J. Kidney Dis. 40, 275-279 (2002).
10. Ympa YP, Sakr Y, Reinhart K, Vincent JL. Has mortality from acute renal failure decreased? A systematic review of the literature. Am. J. Med. 118, 827-832 (2005).
11. Ali T, Khan I, Simpson W et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J.Am. Soc. Nephrol. 18, 1292-1298 (2007).
12. Bagshaw SM, George C, Bellomo R. Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit. Care 11, R68 (2007).
13. Hsu CY McCulloch CE, Fan D, Ordonez JD, Chertow GM, Go AS. Community-based incidence of acute renal failure. Kidney Int. 72, 208-212 (2007).
14. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 8, R204-R212 (2004).
15. Uchino S, Bellomo R, Goldsmith D, Bates S, Kellum J, Ronco C. An assessment of the rifle criteria for acute renal failure in hospitalized patients. Crit. Care Med. 34, 1913-1917(2006).
16. Hoste EA, Clermont G, Kersten A et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit. Care 10, R73 (2006).
17. Bellomo R. The epidemiology of acute renal failure: 1975 versus 2005. Curr. Opin. Crit. Care 12, 557-560 (2006).
18. Lewis J, Salem MM, Chertow GM et al. Atrial natriuretic peptide factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am. J. Kid. Disease 36, 767-774 (2000).
19. Hirschberg R, Kopple J, Lipsett P et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int. 55, 2423-2432 (1999).
20. Stevens LA, Levey AS. Measurement of kidney function. Med. Clin. North Am. 89, 457-473, (2005).
21. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 28, 830-838 (1985).
22. Molitch ME, Rodman E, Hirsch CA, Dubinsky E. Spurious serum creatinine elevations in ketoacidosis. Ann. Intern. Med. 93, 280-281 (1980).
23. Prabhakar SS, Zeballos GA, Montoya-Zavala M, Leonard C. Urea inhibits inducible nitric oxide synthase in macrophage cell line. Am. J. Physiol. 273, C1882-C1888 (1997).
24. 2Cl cotransport in human erythrocytes. J. Clin. Invest. 96, 2126-2132 (1995).
25. Rabb H, Wang Z, Nemoto T, Hotchkiss J, Yokota N, Soleimani M. Acute renal failure leads to dysregulation of lung salt and water channels. Kidney Int. 63, 600-606 (2003).
26. Bagshaw SM, Langenberg C, Bellomo R. Urinary biochemistry and microscopy in septic acute renal failure: a systematic review. Am. J. Kidney Dis. 48, 695-705 (2006).
27. Villa P, Jimenez M, Soriano MC, Manzanares J, Casasnovas P. Serum cytatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit. Care 9, R139-R143 (2005).
28. Chesney PJ, Davis JP, Purdy WK, Wand PJ, Chesney RW Clinical manifestations of toxic shock syndrome. JAMA 246, 741-748 (1981).
29. Diamond JR, Yoburn DC. Nonoliguric acute renal failure associated with a low fractional excretion of sodium. Ann. Intern. Med. 96, 597-600 (1982).
30. Graber M, Lane B, Lamia R, Pastoriza-Munoz E. Bubble cells: renal tubular cells in the urinary sediment with characteristics of viability. J. Am. Soc. Nephrol. 1, 999-1004 (1991).
31. Richmond JM, Sibbald WJ, Linton AM, Linton AL. Patterns of urinary protein excretion in patients with sepsis. Nephron 31, 219-223 (1982).
32. Thorevska N, Sabahi R, Upadya A, Manthous C, Amoateng-Adjepong Y Microalbuminuria in critically ill medical patients: prevalence, predictors, and prognostic significance. Crit. Care Med. 31, 1075-1081 (2003).
33. Gosling P, Brudney S, McGrath L, Riseboro S, Manji M. Mortality prediction at admission to intensive care: a comparison of microalbuminuria with acute physiology scores after 24 hours. Crit. Care Med. 31, 98-103(2003).
34. Gosling P, Czyz J, Nightingale P, Manji M. Microalbuminuria in the intensive care unit: clinical correlates and association with outcomes in 431 patients. Crit. Care Med. 34, 2158-2166 (2006).
35. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin. Sci. (Lond.) 88, 629-633 (1995).
36. Gopal S, Carr B, Nelson P. Does microalbuminuria predict illness severity in critically ill patients on the intensive care unit? A systematic review. Crit. Care Med. 34, 1805-1810 (2006).
37. Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int. 62, 2223-2229 (2002).
38. Miller TR, Anderson RJ, Linas SL et al. Urinary diagnostic indices in acute renal failure: a prospective study. Ann. Intern. Med. 89, 47-50 (1978).
39. Espinel CH. The FENa test. Use in the differential diagnosis of acute renal failure. JAMA 236, 579-581 (1976).
40. Espinel CH, Gregory AW. Differential diagnosis of acute renal failure. Clin. Nephrol. 13, 73-77 (1980).
41. Zarich S, Fang LS, Diamond JR. Fractional excretion of sodium. Exceptions to its diagnostic value. Arch. Intern. Med. 145, 108-112 (1985).
42. Pru C, Kjellstrand CM. The FENa test is of no prognostic value in acute renal failure. Nephron 36, 20-23 (1984).
43. Van Biesen W, Yegenaga I, Vanholder R et al. Relationship between fluid status and its management on acute renal failure (ARF) in intensive care unit (ICU) patients with sepsis: a prospective analysis. J. Nephrol. 18, 54-60 (2005).
44. Kaplan AA, Kohn OF. Fractional excretion of urea as a guide to renal dysfunction. Am. J. Nephrol. 12, 49-54 (1992).
45. Fang L, Sirota R, Ebert T, Lichtenstein N. Low fractional excretion of sodium with contrast media-induced acute renal failure. Arch. Intern. Med. 140, 531-533 (1980).
46. Corwin HL, Schreiber MJ, Fang LS. Low fractional excretion of sodium. Occurrence with hemoglobinuric- and myoglobinuric-induced acute renal failure. Arch. Intern. Med. 144, 981-982 (1984).
47. Vaz AJ. Low fractional excretion of urine sodium in acute renal failure due to sepsis. Arch. Intern. Med. 143, 738-739 (1983).
48. Fushimi K, Shichiri M, Marumo F. Decreased fractional excretion of urate as an indicator of prerenal azotemia. Am. J. Nephrol. 10, 489-494 (1990).
49. Perlmutter M, Grossman SL, Rothenberg S, Dobkin G. Urine serum urea nitrogen ratio; simple test of renal function in acute azotemia and oliguria. JAMA 170, 1533-1537 (1959).
50. Tungsanga K, Boonwichit D, Lekhakula A, Sitprija V. Urine uric acid and urine creatine ratio in acute renal failure. Arch. Intern. Med. 144, 934-937 (1984).
51. Han WK, Bonventre JV. Biologic markers for the early detection of acute kidney injury. Curr. Opin. Crit. Care 10, 476-482 (2004).
52. Herget-Rosenthal S, Feldkamp T, Volbracht L, Kribben A. Measurement of urinary cystatin C by particle-enhanced nephelometric immunoassay: precision, interferences, stability and reference range. Ann. Clin. Biochem. 41, 111-118 (2004).
53. Herget-Rosenthal S, Kribbin A. Urinary cystatin C: pre-analytical and analytical characteristics and its clinical application. Dade Behring J. 13-15 (2004).
54. Coll E, Botey A, Alvarez L et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am. J. Kidney Dis. 36, 29-34 (2000).
55. Hoek FJ, Kemperman FA, Krediet RT A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol. Dial. Transplant. 18, 2024-2031 (2003).
56. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am. J. Kidney Dis. 40, 221-226 (2002).
57. Poge U, Gerhardt T, Stoffel-Wagner B et al. Cystatin C-based calculation of glomerular filtration rate in kidney transplant recipients. Kidney Int. 70, 204-210 (2006).
58. Poge U, Gerhardt T, Stoffel-Wagner B, Klehr HU, Sauerbruch T, Woitas RP Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol. Dial. Transplant. 21, 660-664 (2006).
59. Knight EL, Verhave JC, Spiegelman D et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 65, 1416-1421 (2004).
60. Manetti L, Genovesi M, Pardini E et al. Early effects of methylprednisolone infusion on serum cystatin C in patients with severe Graves' ophthalmopathy. Clin. Chim. Acta 356, 227-228 (2005).
61. Manetti L, Pardini E, Genovesi M et al. Thyroid function differently affects serum cystatin C and creatinine concentrations. J. Endocrinol. Invest. 28, 346-349 (2005).
62. Rule AD, Larson TS. Response to 'Calculation of glomerular filtration rate using serum cystatin C in kidney transplant recipients'. Kidney Int. 70, 1878-1879 (2006).
63. Mishra J, Ma Q, Prada A et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol. 14, 2534-2543 (2003).
64. Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365, 1231-1238 (2005).
65. Mishra J, Ma Q, Kelly C et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr. Nephrol. 21, 856-863 (2006).
66. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S. Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am. J. Nephrol. 26, 287-292 (2006).
67. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E et al. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values? Kidney Blood Press. Res. 30, 408-415 (2007).
68. Hirsch R, Dent C, Pfriem H et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr. Nephrol. 22, 2089-2095 (2007).
69. Trachtman H, Christen E, Cnaan A et al. Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr. Nephrol. 21, 989-994 (2006).
70. Wagener G, Jan M, Kim M et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 105, 485-491 (2006).
71. Parikh CR, Jani A, Mishra J et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am. J. Transplant. 6, 1639-1645 (2006).
72. Melnikov VY, Ecder T, Fantuzzi G et al. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J. Clin. Invest. 107, 1145-1152 (2001).
73. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein C. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am. J. Kidney Dis. 43, 405-414 (2004).
74. Parikh CR, Mishra J, Thiessen-Philbrook H et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 70, 199-203 (2006).
75. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J. Am. Soc. Nephrol. 16, 3046-3052 (2005).
76. Washburn K, Zappitelli M, Arikan A et al. Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrol. Dial. Transplant. 23, 566-572 (2008).
77. Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N. Engl. J. Med. 342, 1301-1308 (2000).
78. Acute Respiratory Distress Syndrome Network. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 283, 1995-2002 (2000).
79. Ichimura T, Bonventre JV, Bailly V et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol. Chem. 273, 4135-4142 (1998).
80. Ichimura T, Hung CC, Yang SA et al. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am. J. Physiol. Renal Physiol. 286, F552-F563 (2004).
81. Vaidya VS, Ramirez V, Ichimura T et al. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am. J. Physiol. Renal Physiol. 290, F517-F529 (2006).
82. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 62, 237-244 (2002).
83. Han WK, Waikar SS, Johnson A et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 73, 863-869 (2008).
84. Zhang P, Rothblum L, Han WK, Blasick T, Potdar S, Bonventre JV. Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int. 73, 608-614 (2008).
85. van Timmeren M, Vaidya V, van Ree R et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 84, 1625-1630 (2007).
86. Liangos O, Perianayagam MC, Vaidya VS et al. Urinary N-acetyl-beta-D-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am. Soc. Nephrol. 18, 904-912 (2007).
87. Chew SL, Lins RL, Daelemans R, Nuyts CD, De Broe ME. Urinary enzymes in acute renal failure. Nephrol. Dial. Transplant. 8, 507-511 (1993).
88. Westhuyzen J, Endre ZH, Reece G, Reith DM, Saltissi D, Morgan TJ. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol. Dial. Transplant. 18, 543-551 (2003).
89. + exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am. J. Kidney Dis. 42, 497-506 (2003).
90. Zhou H, Pisitkun T, Aponte A et al. Exosomal fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int. 70, 1847-1857(2006).
91. Holly MK, Dear JW, Hu X et al. Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. Kidney Int. 70, 496-506 (2006).
92. Molls R, Savransky V, Liu M et al. Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. Am. J. Physiol. Renal Physiol. 290, F1187-F1193 (2006).
93. Muramatsu Y, Tsujie M, Kohda Y et al. Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. Kidney Int. 62, 1601-1610(2002).
94. Reeves WB, Kwon O, Ramesh G. Netrin-1 is an early biomarker of acute kidney injury. Am. J. Physiol. Renal Physiol. 294(4), F731-F738 (2008).
95. Liu KD, Glidden DV, Eisner MD et al. Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. Crit. Care Med. 35, 2755-2761 (2007).
96. Acute Respiratory Distress Syndrome Network. Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. Crit. Care Med. 30, 1-6 (2002).
97. Dennen P, Parikh CR. Biomarkers in acute kidney injury: can we replace serum creatinine? Clin. Nephrol. 68, 269-278 (2007).